ARCHIVES

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

Gallo To Give Scripps Symposium’s Schwartz Lecture

August 9, 1985

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

NCI Sets Initial R01 Payline At 18th Percentile Under CR.

November 24, 2000

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985